Regulatory T Cells and Type 1 Diabetes

WANG Xiao-fei,WANG Xian

DOI: https://doi.org/10.3969/j.issn.1673-2588.2007.02.019

2007-01-01

Abstract:Type 1 diabetes is a T-cell-mediated autoimmune disease,resulting in destruction of the insulin-producing beta cells in the pancreas.However,recent evidence shows that autoimmune processes are composed not only of autoaggressive T-cell responses but also of autoreactive regulatory components.Enhancing regulatory T-cell(Treg) responses,therefore,has become an area of intense focus as a means treating autoimmune diseases like Type 1 diabetes.It is clear that different subsets of regulatory T-cells exist,and their mode of action and phenotype will need to be further characterized.In particular,antigen-specific regulatory T-cells may be useful owing to their ability to act within the affected tissue and suppress autoaggressive T-cells independent of antigen specificity as bystander suppressors in a cytokine-dependent manner.Thus,one can indeed envision autologous Treg therapy in the not too distant future.Application of universal Treg therapy without antigen specificity will lead to systemic immune modulation and suppression,which might be suitable for some systemic but not organ-specific autoimmune disorders.Therefore,antigen-specific induction of Tregs might be preferable-success will be highly dependent on understanding the in vivo set points and precise phenotype of the 'best' antigen-specific Treg for a given disease.